No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Abstract Introduction This study aimed to describe the effects of no-dose full-fluence photodynamic therapy without verteporfin (no-dose PDT) and to compare no-dose PDT with half-dose verteporfin full-fluence photodynamic therapy (HDFF PDT) for managing chronic central serous chorioretinopathy (cCSC...

Full description

Bibliographic Details
Main Authors: Andrea Servillo, Riccardo Sacconi, Ilaria Zucchiatti, Elena Grachova, Lea Querques, Francesco Prascina, Beatrice Tombolini, Giorgio Dorin, Martin Mainster, Francesco Bandello, Giuseppe Querques
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-06-01
Series:Ophthalmology and Therapy
Subjects:
Central serous chorioretinopathy
Choroid
Laser
Macula
Photodynamic therapy
Verteporfin
Online Access:https://doi.org/10.1007/s40123-023-00739-4

Internet

https://doi.org/10.1007/s40123-023-00739-4

Similar Items